PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.245
+0.025 (2.05%)
Jan 7, 2026, 10:46 AM EST - Market open
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $66.25 million as of January 7, 2026. Its market cap has decreased by -15.77% in one year.
Market Cap
66.25M
Enterprise Value
-63.40M
1-Year Change
-15.77%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $66.25M, a decrease of -95.89%. That is a compound annual growth rate of -45.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 64.92M | -2.40% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.15B |
| Johnson & Johnson | 490.73B |
| AbbVie | 388.21B |
| UnitedHealth Group | 311.96B |
| AstraZeneca | 280.48B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.93B |
| Novo Nordisk | 241.55B |